Skip to Content

Focused on results, Dedicated to innovations

AbbVie is a global biopharmaceutical company with focus and capabilities to address some of the world's greatest health challenges.

AbbVie discovers, develops, and commercializes advanced therapies that have an impact on people's lives. Today, our passionate AbbVie team has approximately 29,000 employees working together to help patients around the world.

Investor Resources

FAQs and Tax Information

Answers to questions concerning AbbVie stock purchase, dividends, and how to contact AbbVie's transfer agent and Investor Relations.

Oct 16, 2017 4:00 p.m. ET
Data provided by Nasdaq. Minimum 15 minutes delayed.
ABBV (Common Stock) ABBVCommon Stock
$91.04Price
 + 0.37Change

Events & Presentations

Upcoming Events and
Latest Webcast

View all upcoming and past events.

The principal market of AbbVie's common shares is the New York Stock Exchange. Shares are also listed on the Chicago Stock Exchange and traded on various regional and electronic exchanges. Outside the United States, AbbVie's shares are listed on the NYSE Euronext Paris, and SIX Swiss Exchange.